Literature DB >> 25187669

A young man evaluated for suspicion of lymphoma.

Anthony P Cannella, Joseph M Vinetz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187669      PMCID: PMC4155542          DOI: 10.4269/ajtmh.14-0084

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
A 21-year-old man had moved to Riverside County, California from Botswana at 7 years of age. He presented with B symptoms: intermittent fever, fatigue, and 20 kg weight loss progressive over 6 weeks. He had no relevant past medical history; his last trip to Africa was in 2002. On examination, he had axillary and inguinal lymphadenopathy; nodular skin ulcerations were present on the forehead, fingers, scalp, and chest (Figure 1C). Laboratory studies showed low hemoglobin (10.7 g/dL), a negative Mycobacterium tuberculosis interferon-γ release assay, and a negative serology for human immunodeficiency virus. A concern for lymphoma prompted a positron emission computer tomography scan (PET CT-coronal images shown), which showed extensive tracer uptake in mediastinal and axillary lymph nodes (Figure 1A-anterior coronal image shown), vertebral bodies and pedicles, and the right testis (Figure 1B-posterior coronal image shown).1 An excisional biopsy (hematoxylin and eosin [H&E] stain) of a left axillary lymph node showed spherules consistent with Coccidioides species (Figure 1D). The serum Coccidioides complement fixation titer was 1:512; cerebrospinal fluid analysis was unremarkable. Fluconazole 800 mg/d by mouth led to clinical resolution. Infections with Coccidioides immitis/posadasii are common in the southwestern United States, Mexico, and parts of South America,2 and has recently been found to be expanding in range to previously unsuspected areas such as Washington State.3
Figure 1.

(A and B) Positron emission tomography. (A) Coronal section-anterior view; (B) coronal section-posterior view) of patient with coccidioidomycosis; noted tracer uptake in axillary and mediastinal lymph nodes, cervical and lumbar vertebrae, left ilium, and perineum. (C) Integumenal lesions on patient's anterior chest. (D) Hematoxylin and eosin (H&E) stain of left axillary lymph node biopsy showing Coccidioides spp. spherules within a granuloma.

(A and B) Positron emission tomography. (A) Coronal section-anterior view; (B) coronal section-posterior view) of patient with coccidioidomycosis; noted tracer uptake in axillary and mediastinal lymph nodes, cervical and lumbar vertebrae, left ilium, and perineum. (C) Integumenal lesions on patient's anterior chest. (D) Hematoxylin and eosin (H&E) stain of left axillary lymph node biopsy showing Coccidioides spp. spherules within a granuloma.
  3 in total

1.  F-18 FDG PET/CT imaging of disseminated coccidioidomycosis.

Authors:  Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2006-09       Impact factor: 7.794

2.  Coccidioidomycosis acquired in Washington State.

Authors:  Nicola Marsden-Haug; Marcia Goldoft; Cindy Ralston; Ajit P Limaye; Jimmy Chua; Heather Hill; Larry Jecha; George R Thompson; Tom Chiller
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

3.  AFLP analysis reveals high genetic diversity but low population structure in Coccidioides posadasii isolates from Mexico and Argentina.

Authors:  Esperanza Duarte-Escalante; Gerardo Zúñiga; María Guadalupe Frías-De-León; Cristina Canteros; Laura Rosio Castañón-Olivares; María del Rocío Reyes-Montes
Journal:  BMC Infect Dis       Date:  2013-09-03       Impact factor: 3.090

  3 in total
  1 in total

1.  Coccidioidomycosis in Biopsies with Presumptive Diagnosis of Malignancy in Dogs: Report of Three Cases and Comparative Discussion of Published Reports.

Authors:  Rafael Ramírez-Romero; Rolando Antonio Silva-Pérez; Jorge Lara-Arias; Cecilia Ramírez-Hernández; Iván Alberto Marino-Martínez; Álvaro Barbosa-Quintana; Alfonso López-Mayagoitia
Journal:  Mycopathologia       Date:  2015-09-29       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.